The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 29, 2022

Filed:

May. 10, 2018
Applicants:

Kt & G Corporation, Daejeon, KR;

Korea Ginseng Corp., Daejeon, KR;

Inventors:

Han-Jae Shin, Daejeon, KR;

Hyo Keun Kim, Daejeon, KR;

Moon-Yong Lee, Daejeon, KR;

Hyo-Min Gwak, Daejeon, KR;

Hye-Jeong Min, Daejeon, KR;

Young-Sin Kim, Daejeon, KR;

Chang Kyun Han, Daejeon, KR;

Jongsu Kyung, Daejeon, KR;

Gyo In, Daejeon, KR;

Jong Han Kim, Daejeon, KR;

Sung Won Kim, Daejeon, KR;

Kyoung Hwa Jang, Daejeon, KR;

Seung-Hyung Kim, Daejeon, KR;

Assignees:

KT&G CORPORATION, Daejeon, KR;

KOREA GINSENG CORP., Daejeon, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/537 (2006.01); A61P 11/06 (2006.01); A61P 11/08 (2006.01); A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 36/258 (2006.01);
U.S. Cl.
CPC ...
A61K 36/537 (2013.01); A61K 9/0095 (2013.01); A61K 9/10 (2013.01); A61K 9/16 (2013.01); A61K 9/20 (2013.01); A61K 9/4858 (2013.01); A61K 36/258 (2013.01); A61P 11/06 (2018.01); A61P 11/08 (2018.01);
Abstract

The present invention relates to a composition and health functional food for preventing and treating a respiratory inflammation disease using a mixed herbal mixture. Through various experiments, for example, determination of the cell number of BAL (bronchoalveolar lavage) (Experimental Example 1); Determination of CD11b+/Gr-1+ ratio in leukocyte within BAL fluid (Experimental Example 2); Determination of expressed RNA level of inflammatory cytokines in lung tissue (Experimental Example 3); Determination of expressed RNA level of inflammatory cytokines in BALF (Experimental Example 4); Lung histology (Experimental Example 5); Brief Clinical test (Experimental Example 7) etc, it has been verified that the inventive combined extract showed more potent inhibiting effect on respiratory inflammation disease than each herb extract. Therefore, the herbal extract of the present invention can be usefully used in a pharmaceutical composition, health functional food, and health supplement food for preventing and treating respiratory inflammation disease.


Find Patent Forward Citations

Loading…